Kahweol inhibits lipid accumulation and induces Glucose-uptake through activation of AMP-activated protein kinase (AMPK)
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Weight loss ≥ 5 percent is sufficient to significantly reduce health risks for obese people; therefore, development of novel weight loss compounds with reduced toxicity is urgently required. After screening of natural compounds with antiadipogenesis properties in 3T3-L1 cells, we determined that kahweol, a coffee-specific diterpene, inhibited adipogenesis. Kahweol reduced lipid accumulation and expression levels of adipogenesis and lipid accumulation-related factors. Levels of phosphorylated AKT and phosphorylated JAK2, that induce lipid accumulation, decreased in kahweol-treated cells. Particularly, kahweol treatment significantly increased AMP-activated protein kinase (AMPK) activation. We revealed that depletion of AMPK alleviated reduction in lipid accumulation from kahweol treatment, suggesting that inhibition of lipid accumulation by kahweol is dependent on AMPK activation. We detected more rapid reduction in blood glucose levels in mice administrated kahweol than in control mice. We suggest that kahweol has anti-obesity effects and should be studied further for possible therapeutic applications.
Abstract
Weight loss ≥ 5 percent is sufficient to significantly reduce health risks for obese people; therefore, development of novel weight loss compounds with reduced toxicity is urgently required. After screening of natural compounds with antiadipogenesis properties in 3T3-L1 cells, we determined that kahweol, a coffee-specific diterpene, inhibited adipogenesis. Kahweol reduced lipid accumulation and expression levels of adipogenesis and lipid accumulation-related factors. Levels of phosphorylated AKT and phosphorylated JAK2, that induce lipid accumulation, decreased in kahweol-treated cells. Particularly, kahweol treatment significantly increased AMP-activated protein kinase (AMPK) activation. We revealed that depletion of AMPK alleviated reduction in lipid accumulation from kahweol treatment, suggesting that inhibition of lipid accumulation by kahweol is dependent on AMPK activation. We detected more rapid reduction in blood glucose levels in mice administrated kahweol than in control mice. We suggest that kahweol has anti-obesity effects and should be studied further for possible therapeutic applications.
참고문헌 (34)
- Bray GA, "Why do we need drugs to treat the patient with obesity?", Obesity (Silver Spring), 21, pp.893~899 (2013)
- Li Z, "Meta-analysis : pharmacologic treatment of obesity", Ann Intern Med, 142, pp.532~546 (2005)
- Xia Y, "Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010", Obesity (Silver Spring), 23, pp.1721~1728 (2015)
- Apovian CM, "Pharmacological management of obesity: an endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 100, pp.342~362 (2015)
- Cheung BM, "Safety of antiobesity drugs", Ther Adv Drug Saf, 4, pp.171~181 (2013)
- Khera R, "Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse", JAMA, 315, pp.2424~2434 (2016)
- Yanovski SZ, "Long-term drug treatment for obesity: a systematic and clinical review", JAMA, 311, pp.74~86 (2014)
- Goldstein DJ, "Beneficial health effects of modest weight loss", Int J Obes Relat Metab Disord, 16, pp.397~415 (1992)
- 최혜연, "G protein-coupled receptors in stem cell maintenance and somatic reprogramming to pluripotent or cancer stem cells", BMB Reports, 48(2), pp.68~80 (2015), 생화학분자생물학회
- 강하라, "The role of microRNAs in cell fate determination of mesenchymal stem cells : balancing adipogenesis and osteogenesis", BMB Reports, 48(6), pp.319~323 (2015), 생화학분자생물학회
- Fumimoto R, "The coffee diterpene kahweol prevents osteoclastogenesis via impairment of NFATc1 expression and blocking of Erk phosphorylation", J Pharmacol Sci, 118, pp.479~486 (2012)
- Cárdenas C, "Medina, Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene", PLoS One, 6, pp.e23407~ (2011)
- 전상민, "Regulation and function of AMPK in physiology and diseases", Experimental and Molecular Medicine, 48, pp.1~13 (2016), 생화학분자생물학회
- Oh JH, "The coffee diterpene kahweol induces apoptosis in human leukemia U937 cells through down-regulation of Akt phosphorylation and activation of JNK", Apoptosis, 14, pp.1378~1386 (2009)
- Rosen ED, "MacDougald, Adipocyte differentiation from the inside out", Nat Rev Mol Cell Biol, 7, pp.885~896 (2006)
- Zhang BB, "AMPK : an emerging drug target for diabetes and the metabolic syndrome", Cell Metab, 9, pp.407~416 (2009)
- Morisco F, "Coffee and liver health", J Clin Gastroenterol, 48(Suppl 1), pp.S87~S90 (2014)
- Higdon JV, "Coffee and health: a review of recent human research", Crit Rev Food Sci Nutr, 46, pp.101~123 (2006)
- 김효정, "Caffeine inhibits adipogenesis through modulation of mitotic clonal expansion and the AKT", GSK3 pathway in 3T3-L1 adipocytes, 2016, pp.49(2), 111~115[DOI]
- Gross G, "Analysis of the content of the diterpenes cafestol and kahweol in coffee brews", Food Chem Toxicol, 35, pp.547~554 (1997)
- Rustan AC, "Effect of coffee lipids (cafestol and kahweol) on regulation of cholesterol metabolism in HepG2 cells", Arterioscler Thromb Vasc Biol, 17, pp.2140~2149 (1997)
- Park GH, "The coffee diterpene kahweol suppresses the cell proliferation by inducing cyclin D1 proteasomal degradation via ERK1", 2, JNK and GKS3beta-dependent threonine-286 phosphorylation in human colorectal cancer cells, 2016, pp.95, 142~148
- 최동욱, "The Cytotoxicity of Kahweol in HT-29 Human Colorectal Cancer Cells Is Mediated by Apoptosis and Suppression of Heat Shock Protein 70 Expression", Biomolecules & Therapeutics, 23(2), pp.128~133 (2015), 한국응용약물학회
- Kim HG, "Kahweol blocks STAT3 phosphorylation and induces apoptosis in human lung adenocarcinoma A549 cells", Toxicol Lett, 187, pp.28~34 (2009)
- Moeenfard M, "Anti-Angiogenic Properties of Cafestol and Kahweol Palmitate Diterpene Esters", J Cell Biochem, 117, pp.2748~2756 (2016)
- Xiao-Lin Liu, "Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes", Experimental and Molecular Medicine, 49, pp.1~9 (2017), 생화학분자생물학회
- McGee SL, "AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5", Diabetes, 57, pp.860~867 (2008)
- Stoppani J, "AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle", Am J Physiol Endocrinol Metab, 283, pp.E1239~E1248 (2002)
- Habinowski SA, "The effects of AICAR on adipocyte differentiation of 3T3-L1 cells", Biochem Biophys Res Commun, 286, pp.852~856 (2001)
- Figarola JL, "Smallmolecule COH-SR4 inhibits adipocyte differentiation via AMPK activation", Int J Mol Med, 31, pp.1166~1176 (2013)
- 김정목, "AMPK activators: mechanisms of action and physiological activities", Experimental and Molecular Medicine, 48, pp.1~12 (2016), 생화학분자생물학회
- Davies SP, "5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase- 2C alpha and native bovine protein phosphatase- 2AC", FEBS Lett, 377, pp.421~425 (1995)
- Hardie DG, "AMPK: a key regulator of energy balance in the single cell and the whole organism", Int J Obes (Lond), 32(Suppl 4), pp.S7~S12 (2008)
- Herrero-Martín G, "TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells", EMBO J, 28, pp.677~685 (2009)